Revolution Medicines: RBC raises target price to $260 from $259
RVMD•RBC raised its target price for Revolution Medicines to $260 from $259.
Related News
Targa Resources Corp.: Jefferies cuts target price to $326 from $345
TRGP•
MGP Ingredients to rebrand as Sempreon
MGPI•
NNN REIT declares quarterly dividend of 62 cents per share
NNN•
Comtech Telecommunications Corp: B. Riley cuts target price to $4.75 from $6.00
CMTL•
Lumen, Snowflake plan collaboration to simplify private data connectivity
SNOW•